Thus, activation of the NLRP3 inflammasome triggers an inflammatory cascade that culminates in increased plasma IL-6 and hsCRP levels, both associated with higher ASCVD event rates.13,14 Currently, hsCRP is the primary plasma biomarker used clinically to identify systemic inflammation (Figure 1). Here, NLRP3 is linked to atherosclerosis.